Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder
نویسندگان
چکیده
Introduction Psychedelic-assisted therapy with psilocybin has shown promise in Phase 2 trials for alcohol use disorder (AUD). Set and setting, particularly factors facilitating a connection nature, may positively influence the psychedelic experience therapeutic outcomes. But to date, randomized controlled of interventions enhance set setting psychedelic-assisted are lacking. Methods This was pilot randomized, trial Visual Healing, nature-themed video intervention optimize versus Standard procedures two open-label 25 mg dosing sessions among 20 participants AUD. For first session, Healing viewed videos during preparation session “ascent” “descent” phases while condition completed meditation preparatory wore eyeshades listened music playlist throughout session. second 4 weeks later, chose either or procedures. Primary outcomes were feasibility, safety, tolerability Healing. Secondary exploratory changes use, effects, anxiety stress. Results Nineteen (95%) (mean age 49 ± 11 years, 60% female) 14-week study. During an average 37.9 min 42-min there no video-related adverse events. Peak increase post-psilocybin blood pressure significantly less randomly assigned compared Alcohol decreased both groups stress, similar between groups. Discussion In this study, viewing feasible, safe, well-tolerated Preliminary findings suggest that potential reduce cardiovascular risks therapy, without interfering alcohol-related treatment Studies replicate our as well studies different other medications indications warranted.
منابع مشابه
Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical trial of psilocybin-assisted treatment of alcohol use disorder. Although treatment effects cannot be analyzed until the study is complete, descri...
متن کاملWhy MDMA therapy for alcohol use disorder? And why now?
Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were asso...
متن کاملMedications for Alcohol Use Disorder.
The U.S. Preventive Services Task Force recommends that clinicians screen adults for alcohol misuse and provide persons engaged in risky or hazardous drinking behaviors with brief behavioral counseling to reduce alcohol misuse. However, only a minority of American adults with high-risk alcohol use receive treatment. Three medications are approved by the U.S. Food and Drug Administration to trea...
متن کاملPsilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
UNLABELLED Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction. Although recent studies have investigated the effects of psilocybin in various populations, there have been no studies on the efficacy of psilocybin for alcohol dependence. We conducted a single-group proof-of-concept study to quantify acute eff...
متن کاملPsilocybin and Obsessive Compulsive Disorder.
Obsessive Compulsive Disorder (OCD) is a psychiatric disorder with considerable morbidity and mortality. This condition disables many individuals and is often refractory to treatment. Research suggests that serotonin plays a role in OCD symptom reduction. We present a case of an individual who successfully used psilocybin, a serotonergic agent, to reduce the core symptoms of OCD for several yea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Psychiatry
سال: 2023
ISSN: ['1664-0640']
DOI: https://doi.org/10.3389/fpsyt.2023.1215972